Abstract
In this study, the presence of motor and cognitive disability is described in a cohort of patients with low-grade glioma recruited from a geographical area with a well-defined population located in the middle of Sweden. The study group consisted of 35 patients, of which 24 were evaluated by both a neurologist and a neuropsychologist, and 11 only by a neurologist. The test battery according to EFIT (Edinburgh Functional Impairment Test) was used by the neurologist to measure impairments of limb function, memory and speech. Patients were asked to self-evaluate their deficits in motor function and cognition by responding to a specific questionnaire. In addition, a neuropsychological test battery was used by an experienced neuropsychologist who had no previous contact with the patients. In general, motor impairment was mild and predominantly found in the upper limb. Neuropsychological assessment revealed moderate or severe cognitive impairment in more than half of the patients. This impairment was not detected by neurological examination, and only to some extent reported by the patients them selves. The results show statistical differences in cognitive function, memory and language as recorded by the three assessors. In conclusion, this study demonstrates the usefulness of neuropsychological assessment as a complement to neurological examination to detect cognitive dysfunction in patients with low-grade gliomas.
Similar content being viewed by others
References
Weitzner MA, Meyers CA: Cognitive functioning and quality of life in malignant glioma patients: a review of the literature. Psycho-Oncology 6: 169–177, 1997
Grant R, Slattery J, Gregor A, Whittle IR: Recording neurological impairment in clinical trials of glioma. J Neuro-Oncol 19: 37–49, 1994
Gregor A, Cull A, Traynor E, Stewart M, Lander F, Love S: Neuropsychometric evaluation of long-term survivors of adult brain tumors: relationship with tumour and treatment parameters. Radiother Oncol 41: 55–59, 1996 157
Scheibel RS, Meyers CA, Levin VA: Cognitive dysfunction following surgery for intracerebral glioma: influence of histopathology, lesion location, and treatment. J Neuro-Oncol 30: 61–69, 1996
Sweet J, Nies K, Lorber R, Vick N: Relative absence of neuropsychological deficit in patients with low grade astrocytomas. J Clin Psychol in Medical Settings 1: 83–104, 1994
Clyde Z, Chataway S, Signorini D, Gregor A, Grant R: Significant change in tests of neurological impairment in patients with brain tumors. J Neuro-Oncol 39: 81–90, 1998
Bampoe J, Bauman G, Cairncross J: Adult low-grade gliomas: natural history, prognostic factors, and timing of treatment. In: Rock JP, Rosenblum M, Shaw E, Cairncross J (eds) The Practical Management of Low-grade Primary BrainTumors. Lippincott Williams & Wilkins, Philadelphia, 1999, pp 135–148
Henderson K, Shaw E: Randomized trials of radiation therapy in adult low-grade gliomas. Semin Radiat Oncol 11: 145–151, 2001
Karim AB, Maat B, Hatlevoll R, Menten J, Rutten EH, Thomas DG, Mascarenhas F, Horiot JC, Parvinen LM, van Reijn M, Jager JJ, Fabrini MG, van Alphen AM, Hamers HP, Gaspar L, Noordman E, Pierart M, van Glabbeke M: Randomized trial on dose-response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) study 22844. Int J Radiat Oncol Biol Phys 36: 549–556, 1996
Karim AB, Afra D, Cornu P, Bleehan N, Schraub S, De Witte O, Darcel F, Stenning S, Pierart M, van Glabbeke M: Randomized trial on the efficacy of radiotherapy for cerebral low-grade glioma in the adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BRO4: an interim analysis. Int J Radiat Oncol Biol Phys 52: 316–324, 2002
World Health Organization: International Classification of Functioning, Disability and Health (ICIDH-2). http://www.who.int/icf/ 020901
Taphoorn MJ, Schiphorst AK, Snoek FJ, Lindeboom J, Wolbers JG, Karim AB, Huijgens PC, Heimans JJ: Cognitive functions and quality of life in patients with low-grade gliomas: the impact of radiotherapy. Ann Neurol 36: 48–54, 1994
Klein M, Heimans JJ, Aaronson NK, van der Ploeg HM, Grit J, Muller M, Postma TJ, Mooij JJ, Boerman RH, Beute GN, Ossenkoppele GJ, van Imhoff GW, Dekker AW, Jolles J, Slotman BJ, Struikmans H, Taphoorn MJ: Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study. Lancet 360: 1361–1368, 2002
Vigilani M, Sichez N, Poisson M, Delattre J: A prospective study of cognitive functions following conventional radiotherapy for supratentorial gliomas in young adults: 4-year results. Int J Radiat Oncol Biol Phys 35: 527–533, 1996
Reijneveld JC, Sitskoorn MM, Klein M, Nuyen J, Taphoorn MJ: Cognitive status and quality of life in patients with suspected versus proven low-grade gliomas. Neurology 56: 618–623, 2001
Mattsson B, Wallgren A: Completeness of the Swedish Cancer Register: non-notified cancer cases recorded on death certificates in 1978. Acta Radiol Oncol 23: 305–313, 1984
Helgesson O, Bengtsson C, Lapidus L, Merck C, Sparen P: Malignant disease observed in a cohort of women: a validation of Swedish Cancer Registry data. Scand J Soc Med 22: 46–49, 1994
Kleihues P, Louis DN, Scheithauer BW, Rorke LB, Reifenberger G, Burger PC, Cavenee WK: The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 61: 215–255, 2002
Williams M: The measurement of memory in clinical practice. Br J Soc Clin Psychol 7: 19–34, 1968
Boston Diagnostic Aphasia Examination Bocklet: Les and febiger, 600 South Washington Square, Philadelphia. In: Mahoney F, Barthel D (eds) Functional Evaluation: The Barthel Index. Rehabilitation 14: 61–65, 1965
Brazil L, Thomas R, Laing R, Hines F, Guerrero D, Ashley S, Brada M: Verbally administered Barthel Index as functional assessment in brain tumor patients. J Neuro-Oncol 34: 187–192, 1997
Aaronson N, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC, Kaasa S, Klee M, Osoba D, Razavi D, Rofe P, Schraub S, Sneeuw K, Sullivan M, Takeda F: The European Organization for Research and Treatment of Cancer QLQC30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85: 365–376, 1993
Osoba D, Aaronson NK, Muller M, Sneeuw K, Hsu MA, Yung WK, Brada M, Newlands E: The development and psychometric validation of a brain cancer qualityof-life questionnaire for use in combination with general cancer-specific questionnaries. Qual Life Res 5: 139–150, 1996
Weitzner MA, Meyers CA, Gelke CK, Byrne KS, Cella DF, Levin VA: The functional assessment of cancer therapy (FACT) scale: development of a brain subscale and revalidation of the general version (FACT-G) in patients with primary brain tumors. Cancer 75: 1151–1161, 1995
Smith A: Symbol Digit Modalities Test. Manual. Western Psychological Services, Los Angeles, 1982
Schmidt M: Rey Auditory Verbal and Learning Test. A Handbook.Western Psychological Services, Los Angeles, 1996
Almkvist O: Neuropsychological Test Results of Subjectively Healthy Control Subjects (unpublished report). Huddinge University Hospital, Stockholm
Wechsler D: WAIS-R. Manual. Manual for Wechsler Adult Intelligence Scale-Revised. The Psychological Corporation, San Antonio, 1981
Wechsler D: (Swedish version by Bartfai A, Nyman H, Stegmann B). WAIS-R. Wechsler Adult Intelligence Scale-Revised. Manual. Psykologiförlaget, Stockholm, 1992 158
Gladsjo JA, Miller SW, Heaton RK: Norms for Letter and Category Fluency: Demographic Corrections for Age, Education, and Ethnicity. Psychological Assessment Resources, Inc, Odessa, 1999
Benton AL, Sivan AB, Hamsher K deS, Varney NR, Spreen O: Contributions to Neuropsychological Assessment. A Clinical Manual. 2nd edn., Oxford University Press, New York, 1994
Howell D: Statistical Methods for Psychology. 3rd edn., Duxburry Press, Belmont, Califonia, 1992, pp 148–150
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Påhlson, A., Ek, L., Ahlström, G. et al. Pitfalls in the Assessment of Disability in Individuals with Low-Grade Gliomas. J Neurooncol 65, 149–158 (2003). https://doi.org/10.1023/B:NEON.0000003727.09448.dd
Issue Date:
DOI: https://doi.org/10.1023/B:NEON.0000003727.09448.dd